These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2015172)

  • 21. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cimetidine on carbamazepine auto- and hetero-induction in man.
    Macphee GJ; Thompson GG; Scobie G; Agnew E; Park BK; Murray T; McColl KE; Brodie MJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):411-9. PubMed ID: 6487479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxcarbazepine extended-release formulation in epilepsy.
    Steinhoff BJ
    Expert Rev Clin Pharmacol; 2009 Mar; 2(2):155-62. PubMed ID: 24410646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine.
    Zaccara G; Gangemi PF; Bendoni L; Menge GP; Schwabe S; Monza GC
    Ther Drug Monit; 1993 Feb; 15(1):39-42. PubMed ID: 8451779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.
    Rosaria Muscatello M; Pacetti M; Cacciola M; La Torre D; Zoccali R; D'Arrigo C; Migliardi G; Spina E
    Epilepsia; 2005 May; 46(5):771-4. PubMed ID: 15857446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxcarbazepine: clinical development program.
    Schwabe S
    Epilepsia; 1994; 35 Suppl 5():S51-3. PubMed ID: 8039472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
    Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
    Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
    Keränen T; Sorri A; Moilanen E; Ylitalo P
    Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.
    Kristensen O; Klitgaard NA; Jönsson B; Sindrup S
    Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxcarbazepine].
    Arroyo S
    Neurologia; 2001 Oct; 16(8):370-5. PubMed ID: 11738014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
    Wietholtz H; Zysset T; Kreiten K; Kohl D; Büchsel R; Matern S
    Eur J Clin Pharmacol; 1989; 36(4):401-6. PubMed ID: 2500346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oxcarbazepine in the treatment of epilepsy. A review and update].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of interaction between oxcarbazepine and erythromycin.
    Keränen T; Jolkkonen J; Jensen PK; Menge GP; Andersson P
    Acta Neurol Scand; 1992 Aug; 86(2):120-3. PubMed ID: 1414219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
    Albani F; Baruzzi A;
    Neurol Sci; 2006 Jul; 27(3):173-5. PubMed ID: 16897629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.
    Hellewell JS
    J Affect Disord; 2002 Dec; 72 Suppl 1():S23-34. PubMed ID: 12589900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.